{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:05:44Z","timestamp":1792688744981,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09892-0","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:04:33Z","timestamp":1784167473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tracking outcome changes in benign prostatic hyperplasia trials: a version history review of ClinicalTrials.gov records"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0428-6084","authenticated-orcid":false,"given":"Tanner","family":"Livsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elghzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hazlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellen","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Ito","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"9892_CR1","unstructured":"Food and Drug Administration Amendments Act (FDAAA) of 2007. Accessed July 31, 2025. https:\/\/www.govinfo.gov\/content\/pkg\/PLAW-110publ85\/pdf\/PLAW-110publ85.pdf#page=82."},{"key":"9892_CR2","unstructured":"42 CFR Part 11 -- Clinical Trials Registration and Results Information Submission. Accessed July 31, 2025. https:\/\/www.ecfr.gov\/current\/title-42\/chapter-I\/subchapter-A\/part-11."},{"issue":"7","key":"9892_CR3","doi-asserted-by":"publisher","first-page":"e197242","DOI":"10.1001\/jamanetworkopen.2019.7242","volume":"2","author":"T Chen","year":"2019","unstructured":"Chen T, Li C, Qin R, et al. Comparison of clinical trial changes in primary outcome and reported intervention effect size between trial registration and publication. JAMA Netw Open. 2019;2(7):e197242\u2013e197242.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"9892_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004306","volume":"20","author":"M Holst","year":"2009","unstructured":"Holst M, Haslberger M, Yerunkar S, Strech D, Hemkens LG, Carlisle BG. Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: a meta-research study. PLoS Med. 2009;20(10):e1004306.","journal-title":"PLoS Med"},{"key":"9892_CR5","volume-title":"StatPearls","author":"M Ng","year":"2025","unstructured":"Ng M, Leslie SW, Baradhi KM. Benign prostatic hyperplasia. In: StatPearls. StatPearls Publishing; 2025."},{"key":"9892_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00756-1","author":"S Kaplan","year":"2024","unstructured":"Kaplan S, Kaufman RP, Mueller T, et al. Correction: retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-023-00756-1.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"9892_CR7","unstructured":"45 CFR 46.102 -- Definitions for purposes of this policy. Accessed August 1, 2025. https:\/\/www.ecfr.gov\/current\/title-45\/subtitle-A\/subchapter-A\/part-46\/subpart-A\/section-46.102."},{"key":"9892_CR8","unstructured":"Constructing Complex Search Queries. Clinicaltrials.gov. Accessed July 3, 2025. https:\/\/clinicaltrials.gov\/find-studies\/constructing-complex-search-queries#expansionOp."},{"key":"9892_CR9","unstructured":"PROSPERO. Accessed July 25, 2025. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251080372."},{"key":"9892_CR10","unstructured":"Hazlitt R, Corwin L, Archer D, et al. Tracking outcome changes. OSF. July 17, 2025. Accessed September 16, 2025. https:\/\/osf.io\/rcftg\/?view_only=9a975d90754241aa86bfc7aaca941186."},{"key":"9892_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045105","author":"M Calvert","year":"2021","unstructured":"Calvert M, King M, Mercieca-Bebber R, et al. SPIRIT-PRO extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open. 2021. https:\/\/doi.org\/10.1136\/bmjopen-2020-045105.","journal-title":"BMJ Open"},{"key":"9892_CR12","unstructured":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials. Accessed August 1, 2025. https:\/\/www.equator-network.org\/reporting-guidelines\/consort-harms\/."},{"key":"9892_CR13","unstructured":"Python. Python Software Foundation. Python [Internet]. 2025. Available from: https:\/\/www.python.org\/."},{"key":"9892_CR14","unstructured":"The R project for statistical computing. Accessed August 1, 2025. https:\/\/www.r-project.org\/."},{"key":"9892_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/17562864251335247","author":"A Rivero-de-Aguilar","year":"2025","unstructured":"Rivero-de-Aguilar A, P\u00e9rez-R\u00edos M, Ross JS, Mascare\u00f1as-Garc\u00eda M, Ruano-Ravi\u00f1a A, Puente-Hernandez M, et al. Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study. Ther Adv Neurol Disord. 2025. https:\/\/doi.org\/10.1177\/17562864251335247.","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"9892_CR16","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.21037\/tau-20-1323","volume":"10","author":"S MacLennan","year":"2021","unstructured":"MacLennan S, Williamson PR. The need for core outcome sets in urological cancer research. Transl Androl Urol. 2021;10(6):2832\u20135.","journal-title":"Transl Androl Urol"},{"issue":"9","key":"9892_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107593","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Wang X, Li S, Meng Z, Liu T, Zhang X. Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis. PLoS ONE. 2014;9(9):e107593.","journal-title":"PLoS ONE"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09892-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:10:27Z","timestamp":1791515427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09892-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9892"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09892-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MV reports receipts of funding from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the US Office of Research Integrity, Oklahoma Center for Advancement of Science and Technology, and internal grants from Oklahoma State University Center for Health Sciences, all outside of the present work. AF reports funding from the Center for Integrative Research on Childhood Adversity, Oklahoma Shared Clinical and Translational Resources, and internal Oklahoma State University Center for Health Sciences grants, all outside this work. All other authors have nothing to report.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"599"}}